China has become the world’s leading shipper of humanoid robots, outpacing the United States in unit volume as companies including Unitree Robotics, UBTECH, and Agibot scale up production, according to CNBC’s April 21 report. The development marks a significant milestone in a technology race that has attracted intense attention from investors, manufacturers, and governments on both sides of the Pacific. It also creates a structural problem for US investors: many of the fastest-growing humanoid robotics companies in China are off-limits to American capital due to export control regulations and investment restrictions.
China’s Humanoid Robot Production Advantage
The production advantage that Chinese humanoid robot companies have built is rooted in the same factors that have made China dominant in consumer electronics, electric vehicles, and solar panels: deep supply chain integration, manufacturing scale, and the ability to iterate quickly on hardware designs. Unitree Robotics, which has become one of the most widely recognized humanoid robot brands globally, has been shipping its G1 and H1 models to customers in China and internationally at price points that undercut US competitors significantly.
UBTECH, which has been developing humanoid robots for longer than most Chinese competitors, has been deploying its Walker series robots in manufacturing environments, including automotive assembly lines. Agibot, a newer entrant backed by significant venture capital, has been scaling its production capacity rapidly and has announced partnerships with Chinese industrial companies for deployment in factory settings.
The scale of Chinese humanoid robot production is a function of the country’s manufacturing infrastructure. China has the component supply chains, the assembly capacity, and the engineering talent to produce humanoid robots at volumes that US competitors currently cannot match. This is not a temporary advantage — it reflects structural investments in manufacturing capability that have been built over decades.
The Valuation Gap Between Chinese and US Humanoid Robots
Despite China’s production lead, US humanoid robot companies command significantly higher valuations. Figure AI, which has partnerships with BMW and has been developing its humanoid robot for industrial applications, has raised capital at valuations that far exceed those of comparable Chinese companies. Boston Dynamics, now owned by Hyundai, has brand recognition and a track record in dynamic robotics that commands a premium. Apptronik, which has a partnership with NASA and Mercedes-Benz, has attracted significant investment at high valuations.
The valuation gap reflects several factors. US companies benefit from easier access to US institutional capital, which has been flowing heavily into robotics. They also benefit from the perception — accurate or not — that they are developing more sophisticated AI software to control their robots. Chinese companies, by contrast, are often valued more like manufacturing businesses than software companies, which compresses their multiples even when their technology is competitive.
This gap is beginning to close as Chinese humanoid robot companies demonstrate production scale and real-world deployment results. Unitree’s robots have been deployed in a wide range of settings, from research laboratories to entertainment venues to industrial pilots, and the company has been publishing performance data that challenges the narrative of US technological superiority in robotics.
US Investors Largely Locked Out
The investment restriction problem is significant. US regulations on investment in Chinese technology companies — particularly those with potential military applications — have created a complex compliance environment that makes it difficult for American institutional investors to take positions in Chinese humanoid robot companies. Humanoid robots, with their potential applications in military logistics, surveillance, and autonomous operations, are particularly sensitive from a regulatory standpoint.
This means that US investors who want exposure to the humanoid robot sector are largely limited to US companies, which are less production-mature and more expensively valued. The result is a bifurcated investment landscape in which the companies with the most production scale are inaccessible to the largest pools of capital, while the companies with the highest valuations are producing at lower volumes.
For Chinese humanoid robot companies, the investment restriction is a mixed outcome. On one hand, it limits their access to US capital markets and the validation that comes with US institutional investment. On the other hand, it reduces the pressure to optimize for US investor expectations and allows companies to focus on the Chinese market, where government support for robotics deployment is strong and customer relationships are easier to manage.
The Beijing Auto Show Robotics Preview
The humanoid robot story intersects with the 2026 Beijing Auto Show, which opens on April 24 and is expected to feature significant humanoid robot demonstrations from Chinese manufacturers. Several Chinese automakers have announced plans to deploy humanoid robots in their manufacturing facilities, and the auto show will serve as a showcase of their integration into industrial production. This deployment pipeline, automotive manufacturing as the first large-scale commercial use case for humanoid robots, is one of the key drivers of China’s production ramp.
The combination of production scale, government support, and a clear near-term deployment use case in automotive manufacturing gives Chinese humanoid robot companies a structural advantage that is difficult to replicate quickly. Whether US companies can close the production gap before Chinese companies establish dominant market positions in the industrial robotics sector is one of the defining questions of technology competition in 2026.